COVID-19 Patients Admitted to the ICU

Covid19 Clinical Trial

Official title:

Prognostic Factors and Predictors of Mortality in COVID-19 Patients Admitted to the ICU. An Aid for Triage, Counseling, and Resource Allocation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04816786
• Other study ID #: 1591/2020
• Status: Recruiting
• Start date: January 1, 2021
• Est. completion date: July 1, 2021

Study information

• Verified date: March 2021
• Source: Ministry of Health, Kuwait
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A retrospective analysis of the adult COVID-19 patients admitted to the ICU. A chart review will be conducted and multiple baseline characteristics, demographics, and treatments given will be recorded. Variables collected will include Age, Gender, BMI, Smoking status, Past medical history, Vital signs on admission, symptoms on admission, duration of symptoms, laboratory results on admission, treatment given. Treatment options will include (Steroids, plasma exchange, IVIG, antibiotics, mode of respiratory support). Primary outcomes will include; Death, duration of ICU stay, duration of mechanical ventilation, in-hospital complications. A regression model will be used to predict poor prognostic factors. Inclusion criteria: patients with confirmed PCR results for COVID-19 AND require ICU admission. Exclusion criteria: those with negative results, pediatric patients and those not requiring ICU admission.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: July 1, 2021
• Est. primary completion date: June 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adults
• Positive PCR test for COVID-19
• Require admission to ICU

Exclusion Criteria:

• Pediatric patients\
• Any patient not requiring admission to ICU

Related Conditions & MeSH terms

• Covid19

Intervention

Other:
• no intervention will be administered, this is a retrospective observational study.
no intervention will be administered, this is a retrospective observational study.

Locations

Country	Name	City	State
Kuwait	Mubarak al Kabeer hospital	Kuwait	Outside U.S./Canada

Sponsors (1)

Lead Sponsor	Collaborator
Ministry of Health, Kuwait

Country where clinical trial is conducted

Kuwait, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Death	Death Vs No Death	30 day mortality
Primary	Duration of ICU stay	Duration of ICU stay	30 days
Primary	Duration of mechanical ventilation	The duration the patient required support from a mechanical ventilator	30 days
Secondary	In-Hospital complications	Wether patients developed in hospital complications.	30 days